BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12243250)

  • 1. Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies.
    Albertini R; Moratti R; De Luca G
    Curr Mol Med; 2002 Sep; 2(6):579-92. PubMed ID: 12243250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis.
    Thomas SR; Stocker R
    Free Radic Biol Med; 2000 Jun; 28(12):1795-805. PubMed ID: 10946221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
    Aviram M
    Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic.
    Fuhrman B; Volkova N; Rosenblat M; Aviram M
    Antioxid Redox Signal; 2000; 2(3):491-506. PubMed ID: 11229363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid peroxidation and its role in atherosclerosis.
    Esterbauer H; Wäg G; Puhl H
    Br Med Bull; 1993 Jul; 49(3):566-76. PubMed ID: 8221023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.
    Aviram M
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):599-608. PubMed ID: 8877334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized low-density lipoprotein and atherosclerosis.
    Devaraj S; Jialal I
    Int J Clin Lab Res; 1996; 26(3):178-84. PubMed ID: 8905449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.
    El-Swefy S; Schaefer EJ; Seman LJ; van Dongen D; Sevanian A; Smith DE; Ordovas JM; El-Sweidy M; Meydani M
    Atherosclerosis; 2000 Apr; 149(2):277-86. PubMed ID: 10729377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.
    Islam KN; O'Byrne D; Devaraj S; Palmer B; Grundy SM; Jialal I
    Atherosclerosis; 2000 May; 150(1):217-24. PubMed ID: 10781654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation.
    Frei B
    Crit Rev Food Sci Nutr; 1995 Jan; 35(1-2):83-98. PubMed ID: 7748483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective.
    Jialal I; Devaraj S
    Clin Chem; 1996 Apr; 42(4):498-506. PubMed ID: 8605665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen radicals and atherosclerosis.
    Carpenter KL; Brabbs CE; Mitchinson MJ
    Klin Wochenschr; 1991 Dec; 69(21-23):1039-45. PubMed ID: 1798277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical-mediated oxidation of isolated human very-low-density lipoprotein.
    Mohr D; Stocker R
    Arterioscler Thromb; 1994 Jul; 14(7):1186-92. PubMed ID: 8018676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers.
    Fuller CJ; Grundy SM; Norkus EP; Jialal I
    Atherosclerosis; 1996 Jan; 119(2):139-50. PubMed ID: 8808491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of LDL oxidation by antioxidants.
    Esterbauer H; Waeg G; Puhl H; Dieber-Rotheneder M; Tatzber F
    EXS; 1992; 62():145-57. PubMed ID: 1450582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antioxidants on the oxidative susceptibility of low-density lipoprotein.
    Hirano R; Kondo K; Iwamoto T; Igarashi O; Itakura H
    J Nutr Sci Vitaminol (Tokyo); 1997 Aug; 43(4):435-44. PubMed ID: 9328862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modified low-density lipoprotein].
    Yoshida H; Nakamura H
    Nihon Rinsho; 1994 Dec; 52(12):3090-5. PubMed ID: 7853694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice.
    Maor I; Hayek T; Coleman R; Aviram M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2995-3005. PubMed ID: 9409286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E supplementation in hyperlipidaemic patients: effect of increasing doses on in vitro and in vivo low-density lipoprotein oxidation.
    Wen Y; Killalea S; Norris LA; Cooke T; Feely J
    Eur J Clin Invest; 1999 Dec; 29(12):1027-34. PubMed ID: 10583450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.